SCHEMBL12463556

SCHEMBL12463556

CC(C)(C)OC(=O)N[C@H](C(=O)N1CCCC1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.45
HPGD P15428 1/20 0.43
CTSL P07711 2/20 0.43
AAK1 Q2M2I8 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
GAA P10253 1/20 0.43
CTSK P43235 4/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TP53 P04637 1/20 0.42
CTSB P07858 1/20 0.41
ITGB3 P05106 4/20 0.41
ITGA2B P08514 4/20 0.41
CTSS P25774 1/20 0.41
PREP P48147 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22501529 1.00 EPHX1 (0.45) EPHX1HPGDCTSLAAK1CA1
SCHEMBL18215143 0.94 AAK1 (0.44) HPGDCTSLAAK1CA1CA2
SCHEMBL28650981 0.94 AAK1 (0.44) HPGDCTSLAAK1CA1CA2
SCHEMBL18215087 0.94 AAK1 (0.44) HPGDCTSLAAK1CA1CA2
SCHEMBL9102139 0.91 AAK1 (0.44) HPGDCTSLAAK1CA1CA2
SCHEMBL9102145 0.91 AAK1 (0.44) HPGDCTSLAAK1CA1CA2
SCHEMBL21647650 0.91 EPHX1 (0.42) EPHX1CTSLAAK1CA1CA2
SCHEMBL28526295 0.91 EPHX1 (0.42) EPHX1CTSLAAK1CA1CA2
SCHEMBL6801509 0.89 ALDH1A1 (0.50) EPHX1CTSLAAK1GAACTSK
SCHEMBL11938111 0.89 ALDH1A1 (0.50) EPHX1CTSLAAK1GAACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946607-A1 BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS Hepagene Therapeutics (HK) Limited (HK) 2022-02-09 EP disclosed
WO-2020206000-A1 BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS Hepagene Therapeutics (HK) Limited (CN) 2020-10-08 WO disclosed
EP-2340830-A2 Hepatitis C Virus Inhibitors Bristol-Myers Squibb Company (US) 2011-07-06 EP disclosed